Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report issued on Wednesday. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Price Performance

AMPE opened at $0.00 on Wednesday. The firm has a market cap of $2,497.00, a PE ratio of 0.00 and a beta of 3.67. Ampio Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $7.47.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.